February 17, 2026

FDA Approves New Treatment for Patients with Locally Advanced Pancreatic Cancer: What You Need to Know

“[In the clinical trial], treatment with Optune Pax resulted in a statistically significant improvement in overall survival without adding to the systemic side effects commonly associated with existing therapies. It also significantly extended time to pain progression, helping to preserve overall quality of life, which is a priority when I am treating patients living with pancreatic cancer,” Dr. Picozzi said. “With FDA approval, Optune Pax has the potential to be practice changing for the treatment of patients with locally advanced pancreatic cancer.”

February 17, 2026

FDA Approves New Treatment for Patients with Locally Advanced Pancreatic Cancer: What You Need to Know – Pancreatic Cancer Action Network

February 17, 2026

Doxycycline-Induced Phototoxicity Localized to Vitiligo-Affected and Sun-Exposed Skin – Cureus

February 16, 2026

Tim Beckner: Colorectal Cancer – Cleveland Clinic

February 16, 2026

Cheaper medicines for people living with cystic fibrosis – MBS Online